Growth Metrics

Sarepta Therapeutics (SRPT) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -133.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -133.67%
Dec 31, 2025 114.15%
Sep 30, 2025 129.93%
Jun 30, 2025 28.28%
Mar 31, 2025 28.17%
Dec 31, 2024 568.33%
Sep 30, 2024 -102.93%
Jun 30, 2024 -32.13%
Mar 31, 2024 11.78%
Dec 31, 2023 19.61%
Sep 30, 2023 -80.64%
Jun 30, 2023 68.96%
Mar 31, 2023 39.36%
Dec 31, 2022 -16.92%
Sep 30, 2022 45.25%
Jun 30, 2022 -57.45%
Mar 31, 2022 -98.41%
Dec 31, 2021 77.87%
Sep 30, 2021 32.38%
Jun 30, 2021 98.55%
Mar 31, 2021 135.05%
Dec 31, 2020 36.92%
Sep 30, 2020 -24.36%
Jun 30, 2020 -19.50%
Mar 31, 2020 -27.74%
Dec 31, 2019 27.77%
Sep 30, 2019 -55.45%
Jun 30, 2019 24.51%
Mar 31, 2019 90.95%
Dec 31, 2018 -50.44%
Sep 30, 2018 -59.32%
Jun 30, 2018 -163.45%
Mar 31, 2018 -32.48%
Dec 31, 2017 -132.55%
Sep 30, 2017 100.69%
Jun 30, 2017 -91.02%
Mar 31, 2017 46.62%
Dec 31, 2016 -523.01%
Sep 30, 2016 100.80%
Jun 30, 2016 283.33%
Mar 31, 2016 65.29%
Dec 31, 2015 -448.54%
Sep 30, 2015 627.45%
Jun 30, 2015 121.90%
Mar 31, 2015 453.18%
Dec 31, 2014 294.80%
Sep 30, 2014 -300.40%
Jun 30, 2014 -49.27%
Mar 31, 2014 -715.59%
Dec 31, 2013 -17.48%
Sep 30, 2013 -50.80%